Novartis Ag (NVSEF) Current Assets (2009 - 2025)

Novartis Ag has disclosed Current Assets across 12 years of filings, most recently posting $30.5 billion for Q4 2025.

• Current Assets for Q4 2025 came in at $30.5 billion, up 2.55% year-over-year; the trailing twelve-month figure through Dec 2025 was $30.5 billion (up 2.55% YoY), and the FY2025 annual result was $30.5 billion, up 2.55% from the prior year.
• Current Assets came in at $30.5 billion for Q4 2025 at Novartis Ag, up from $25.9 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $45.7 billion in Q4 2021 to a low of $25.7 billion in Q2 2024.
• The 5-year median for Current Assets is $30.9 billion (2021), against an average of $32.8 billion.
• Across the five-year window, Current Assets surged 54.07% in 2021 and declined 23.29% in 2024, its largest moves.
• Novartis Ag's Current Assets stood at $45.7 billion in 2021, then declined by 19.27% to $36.9 billion in 2022, then declined by 17.42% to $30.5 billion in 2023, then fell by 2.55% to $29.7 billion in 2024, then gained by 2.55% to $30.5 billion in 2025.
• The last three Current Assets figures came in at $30.5 billion (Q4 2025), $25.9 billion (Q2 2025), and $29.7 billion (Q4 2024), per Business Quant data.